These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19221213)

  • 1. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study.
    Matrozova J; Steichen O; Amar L; Zacharieva S; Jeunemaitre X; Plouin PF
    Hypertension; 2009 Apr; 53(4):605-10. PubMed ID: 19221213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.
    Fallo F; Veglio F; Bertello C; Sonino N; Della Mea P; Ermani M; Rabbia F; Federspil G; Mulatero P
    J Clin Endocrinol Metab; 2006 Feb; 91(2):454-9. PubMed ID: 16291704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin sensitivity in patients with primary aldosteronism: a follow-up study.
    Catena C; Lapenna R; Baroselli S; Nadalini E; Colussi G; Novello M; Favret G; Melis A; Cavarape A; Sechi LA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3457-63. PubMed ID: 16822818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired glucose homeostasis in non-diabetic Greek hypertensives with diabetes family history. Effect of the obesity status.
    Vyssoulis GP; Liakos CI; Karpanou EA; Triantafyllou AI; Michaelides AP; Tzamou VE; Markou MI; Stefanadis CI
    J Am Soc Hypertens; 2013; 7(4):294-304. PubMed ID: 23562108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose metabolism in patients with essential hypertension.
    García-Puig J; Ruilope LM; Luque M; Fernández J; Ortega R; Dal-Ré R;
    Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
    Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA
    J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry.
    Hanslik G; Wallaschofski H; Dietz A; Riester A; Reincke M; Allolio B; Lang K; Quack I; Rump LC; Willenberg HS; Beuschlein F; Quinkler M; Hannemann A;
    Eur J Endocrinol; 2015 Nov; 173(5):665-75. PubMed ID: 26311088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of dyslipidemia and metabolic syndrome risk factor in overweight and obese children.
    Casavalle PL; Lifshitz F; Romano LS; Pandolfo M; Caamaño A; Boyer PM; Rodríguez PN; Friedman SM
    Pediatr Endocrinol Rev; 2014 Dec; 12(2):213-23. PubMed ID: 25581987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
    J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the treatment of primary hyperaldosteronism influence glucose tolerance?
    Strauch B; Widimský J; Sindelka G; Skrha J
    Physiol Res; 2003; 52(4):503-6. PubMed ID: 12899664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years.
    Wu VC; Chueh SJ; Chen L; Chang CH; Hu YH; Lin YH; Wu KD; Yang WS;
    J Hypertens; 2017 Aug; 35(8):1698-1708. PubMed ID: 28661412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it.
    Ruan X; Jin J; Hua L; Liu Y; Wang J; Liu S
    Menopause; 2010; 17(3):566-70. PubMed ID: 20054286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the incidence and clinical significance of the metabolic syndrome in postmenopausal women in Lodz region].
    Nadel I; Cypryk K; Pertyński T; Sobczuk A; Stetkiewicz T
    Pol Arch Med Wewn; 2001 Sep; 106(3):823-8. PubMed ID: 11928592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose homeostasis in hypertensive subjects.
    Korhonen P; Aarnio P; Saaresranta T; Jaatinen P; Kantola I
    Hypertension; 2008 Apr; 51(4):945-9. PubMed ID: 18285613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis.
    Chen W; Li F; He C; Zhu Y; Tan W
    Ir J Med Sci; 2014 Jun; 183(2):283-91. PubMed ID: 23990176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster.
    von Eckardstein A; Schulte H; Assmann G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3101-8. PubMed ID: 10999793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worsening of lipid metabolism after successful treatment of primary aldosteronism.
    Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M
    Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.